News | December 12, 2022
Merck begins Tender Offer to acquire Imago BioSciences
As a result, Imago will become a subsidiary of Merck.
As a result, Imago will become a subsidiary of Merck.
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
Acquisition expands Merck’s growing hematology portfolio
Strand’s new offering will help people better understand and manage diseases through genomic sequencing
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
The company has reported total income of Rs. 4.59 crores during the period ended September 30, 2022
The company has reported total income of Rs. 114.77 crores during the period ended September 30, 2022.
The Group will continue to make proactive investments of its management resources in the life science business
R&D center would be doing a lot of new product generation projects, process optimization, scale-up and product life cycle management work, full synthetic labs, the kilo labs, the process safety labs, and the population lab
The company has reported total income of Rs. 77.60 crores during the period ended September 30, 2022
Subscribe To Our Newsletter & Stay Updated
